Yuhan Zheng

Title: Yuhan Zheng: Innovator in Multiple Sclerosis Treatment

Introduction

Yuhan Zheng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical research, particularly in the treatment of multiple sclerosis. His innovative work has led to the development of a unique protein that holds promise for therapeutic applications.

Latest Patents

Yuhan Zheng holds a patent for a protein and its use in treating multiple sclerosis. The patent details the extracellular matrix protein 1 (ECM1) and a fusion protein known as Fc-ECM1, which combines ECM1 with the Fc sequence. The patent also includes information on the cloning, construction, and expression of the protein, as well as its application in preparing a pharmaceutical composition for treating multiple sclerosis. He has 1 patent to his name.

Career Highlights

Yuhan Zheng is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work is characterized by a strong focus on innovative solutions to complex medical challenges. His contributions have been recognized within the scientific community, and he continues to push the boundaries of research in his field.

Collaborations

Yuhan Zheng has collaborated with notable colleagues, including Bing Jiang Sun and Pan Su. These partnerships have enhanced his research efforts and contributed to the advancement of knowledge in the treatment of multiple sclerosis.

Conclusion

Yuhan Zheng is a dedicated inventor whose work in developing a protein for treating multiple sclerosis showcases his commitment to medical innovation. His contributions are paving the way for new therapeutic options in the fight against this challenging condition.